baber/WOPTO huggingface dataset:
Patent IE-35811-L (IE)
Title: Triazolo diazepines
IPC: C07D243/16
Filed: 1971-11-15
Abstract: Compounds of the class of 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-lower alkanols, and their ethers and esters, 1-(fluoro-lower alkyl)-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines and the 5-oxides and pharmaceutically acceptable acid addition salts thereof have central depressant properties, in particular antiaggressive and anticonvulsant actions, and are active ingredients for pharmaceutical compositions. Specific embodients are 6-phenyl-8-chloro-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-methanol and 1-(fluoromethyl)6-phenyl-8-chloro-4H-s-triazolo[4,3-a][1,4]benzodiazep ine.
[US4427590A]
Patent IE-811852-L (IE)
Title: Variable speed belt drive
IPC: F16H9/12
Filed: 1981-08-14
Abstract: A variable speed belt drive in which the axially moveable sheave flange is connected to the drive shaft by a flexible element which performs the function of transmitting the torque from the shaft to the axially moveable flange, and which defines a fluid pressure chamber for applying a variable pressure to the moveable flange for moving the flange axially on the shaft as the pressure in the chamber is varied by the operation of a control device. The flexible element may be an annular member having a generally U-shaped configuration with inwardly extending side walls, one of the side walls being connected to the flange and the other side wall being connected to a flange-like member rigidly mounted on the shaft. Passages are provided through the shaft to connect the chamber with a source of controlled pressure. The hub of the moveable flange is preferably not connected by any direct means, such as keys or splines, to the shaft but, except for the flexible element and related structure, is free to rotate relative to the shaft, and the shaft preferably has a smooth cylindrical surface at the section over which the moveable flange hub moves.
[US4384863A]
Patent IE-871876-L (IE)
Title: IMIDAZO (2,1-a) ISOQUINOLINES
IPC: A61K31/47
Filed: 1987-07-13
Abstract: Compounds of formula I <CHEM> wherein each R independently is hydrogen or methyl R1 is in 8- or 9-position and represents hydrogen, chloro, fluoro or C 1-3alkyl and R2 represents thienyl, furyl or <CHEM> wherein each Ro represents independently hydrogen, fluoro, chloro, C 1-10alkyl, C 1-10alkoxy or C 1-10alkylthio or one Ro is hydrogen and the other represents tri-(C 1-3alkyl)silyl, trifluoromethyl, phenyl, monochlorophenyl, monofluorophenyl, <CHEM> wherein X, Y, R3, R3' or R4 are as defined herein or two Ro's on adjacent carbon atoms form methylenedioxy. The compounds are indicated for use in treating PAF-mediated bronchocontriction and extravasation
Patent IE-792507-L (IE)
Title: Process for preparing pyrogallol
IPC: C07C37/07
Filed: 1979-12-21
Abstract: Pyrogallol or a salt thereof is prepared by a process comprising deoximating cyclohexane-1,2,3-trione oxime or an oxime derivative thereof or a salt of either. Preferably the oxime itself is exployed, especially the 1,3-dioxime. The deoximation is preferably effected by hydrolysis.
Patent IE-883591-L (IE)
Title: Data handling apparatus
IPC: H04L12/403
Filed: 1988-12-01
Abstract: Data handling apparatus comprises a host computer (2) which controls a network controller (3), and a network of terminals (T1) to (T12) under the control of the network controller (3). The network controller (3) transmits data from the terminals (T1) to (T12) to the host computer (2). The host computer (2) controls the polling sequence by which the network controller polls the terminals (T1) to (T12). On a terminal (T1) to (T12) going off-line, the host computer removes it from the polling sequence and stores the identity of the terminal for a predetermined time period. After the predetermined time period having timed out, the host computer (2) returns the off-line terminal into the polling sequence of the network controller (3). Should the off-line terminal be found still to be off-line it is removed for a greater predetermined time period. <IMAGE>
[GB2225690A]
Patent NO-753391-L (NO)
Inventor: KARJALAINEN A
IPC: C07D209/08
Filed: 1975-10-08
Abstract: Organiske forbindelser samt fremgangsmåte for deres fremstilling.
Patent NO-842247-L (NO)
Inventor: BARTH WAYNE ERNEST
IPC: C07D499/00
Filed: 1984-06-05
Abstract: A process for the preparation of beta-lactamase inhibiting 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide and derivatives. R- and S-1-(ethoxycarbonyloxy)ethyl 6-alpha-(aminomethyl)penicillanate 1,1-dioxide are specifically described.
Patent NO-844261-L (NO)
Title: Farmasoeytisk pellet
Inventor: WHITEHEAD DEREK JAMES
IPC: A61K9/00
Filed: 1984-10-25
Abstract: Pellet for anvendelse på drøvtygger, hvor den skal ligge i nett-magen og frigjøre suksessive doser av et aktivt middel, som f.eks. et anthelmintikum.., som innbefatter en sammen-stilling (10) av skiver (12) som hver har en periferilist (14) på den ene siden og list forskjvet innover på skiven (16) på den andre siden, slik at skivene kan settes sammen ved hjelp av listene (14, 16) og derved definerer hulrom (18) som hvert inneholder en dose av det aktive middel (24) . En belastnings-plugg (20) tilveiebringes i den ene enden av sammenstillingen (10) som, med unntak av den ene enden, omsluttes av et plast-dekke (26) slik at magesaftene kan angripe og løse opp suksessive skiver (12) og frigjøre suksessive doser (24). Skivene (12) er av en magnesiumbasert legering, og pluggen (20) er av en sinkbasert legering.
Patent NO-864270-L (NO)
Inventor: TIMMER KLAAS
IPC: A61K31/285
Filed: 1986-10-24
Abstract: Novel bis[bis(diphenylphosphino)hydrocarbon] and bis[diphenylphosphino-diphenylarsino)hydrcarbon]-group VIII metal compounds of the formula 1 of the formula sheet, whereinD, = D<sub>2</sub> = phosphorus or D, = phosphorus and D<sub>2</sub> = arsenic;A = (CH<sub>2</sub>)<sub>2</sub> or cis-CH = CH;X, = X<sub>2</sub> (both if present) = halo or nitrato or X, + X = peroxo;Y (if present) = halide, nitrate, perchlorate, triflate or tetrahaloferrate (III);n = 0, 1 or 2;M = Fe(II), Fe(III), Co(II), Rh(I), Rh(III), Ir(I), Ir(III), Ni(II) or Pd(II),showing a tumor cell growth-inhibiting activity, novel pharmaceutical compositions containing said compounds and a method for treating tumor cells, sensitive to said compounds.
Patent NO-870552-L (NO)
Inventor: SACHS HANS IMMO
IPC: C08G18/70
Filed: 1987-02-12
Abstract: This invention relates to formaldehyde-free, aqueous glue dispersions which contain polyisocyanates. These systems are particularly suitable for gluing veneers and surface materials on wood and wood products. The systems are prepared from polyisocyanates in combination with extenders based on flours and cold water-soluble of hydrolyzed natural starch. In this process, polyisocyanates or aqueous dispersions thereof are added while stirring to aqueous solutions or mixtures of starch and flour. The extender-containing adhesive systems are aqueous glue dispersions having increased service life which in their preferred embodiment contain about 15 to 30% by weight of polyisocyanates, preferably polyphenyl-polymethylene polyisocyanate (PMDI), 10 to 15% by weight of starch which is soluble in cold water and 14 to 25% by weight of (cereal) flour and optionally, other additives and the appropriate quantity of water adding up to 100% by weight. The glue dispersions are easily applied with glue spreading machines and if applied in suitable quantities do not bleed through veneers. The implements used for applying the glues can easily be cleaned by rinsing them with water. The invention is also directed to the use of the glue dispersions for gluing, particularly for gluing veneers or other surface coating materials to wood or wood products.
Patent NO-873162-L (NO)
Inventor: BAECHLI EMIL
IPC: F24J2/50
Filed: 1987-07-28
Abstract: PCT No. PCT/CH86/00166 Sec. 371 Date Jul. 22, 1987 Sec. 102(e) Date Jul. 22, 1987 PCT Filed Dec. 1, 1986 PCT Pub. No. WO87/03327 PCT Pub. Date Jun. 4, 1987.A building and/or light element comprises at least two parallel wall elements (1) between which support elements (2) for the formation of an evacuated interspace (3) are placed and the wall elements are connected by a flexible seal on the edges. The distance of wall elements (1) is less than 0.5 mm and support elements (2) are formed as disks lying flat between wall elements (1).
Patent NO-873621-L (NO)
Inventor: EMMERLING WINFRIED
IPC: C09J175/04
Filed: 1987-08-27
Abstract: Alkoxysilane-terminated, moisture-hardening polyurethanes obtained by reaction of OH-terminated diols and/or triols with diisocyanates to form NCO-terminated polyurethanes having an NCO functionality of at least 2, and reaction of some of the NCO groups with aliphatic alcohols to form a polyurethane having an NCO functionality of at least 1 and less than 2, or by reaction of the OH-terminated linear diols or triols with a mixture of mono- and diisocyanates to form NCO-terminated polyurethanes having an NCO functionality of at least 1 and less than 2, followed by a reaction of substantially all the free NCO functions of the polyurethanes obtained with aminoalkyl, mercaptoalkyl or epoxyalkyl alkoxysilanes. The polyurethanes thus obtained are particularly suitable as a basis for moisture-hardening one-component sealing compounds and adhesives.
Patent NO-884596-L (NO)
Inventor: YIM ZACHARY
IPC: A61K38/21
Filed: 1988-10-14
Abstract: An insoluble zinc-protamine alpha interferon complex useful as an injectable sustained release dosage form for administering alpha interferon is disclosed.
Patent NO-892293-L (NO)
Inventor: DUKES MICHAEL
IPC: A61P13/02
Filed: 1989-06-05
Abstract: The invention relates to a therapeutic product comprising an oestrogen and a pure antioestrogen for simultaneous, sequential or separate use in selective oestrogen therapy of perimenopausal or postmenopausal conditions; to a process for the manufacture of said product and to a pharmaceutical composition containing said product. The invention also relates to a pharmaceutical composition comprising an oestrogen and a pure antioestrogen and to a process for the manufacture of said composition.
Patent NO-894474-L (NO)
Inventor: WAETJEN FRANK
IPC: A61P25/08
Filed: 1989-11-09
Abstract: A novel chemical process for preparing imidazoquinoxalines bearing hydrogen substitution in the 5-position comprises dealkylation of the novel corresponding 5-tert-butyl compound (which also has vaulable pharmacological properties).
Patent NO-894851-L (NO)
Title: Byggeelement for laftekonstruksjoner.
Inventor: MALUM HANS
IPC: E04B2/70
Filed: 1989-12-05
Abstract: Byggeelement for reising av laftekonstruksjoner av tre, særlig hytter og hus. En bjelke (12) omfatter sidevanger (14A, 14B, 16A, 16B, 19A, 19B) som mellom seg danner hulrom for opptak av et termisk isolerende medium eller materiale. De to sidevangene danner ved enden utstikk (20A, 20B) som er forsynt med innhakk fra overside og fra underside som motsvarer utstikkenes tykkelse. Et klossformet dekkelement (11) med profil som tilsvarer byggelementets hoveddel og med blindutsparinger (31A, 31B) inn fra enden, som motsvarer utstikkenes profil, er beregnet for påsetting på byggelementets ende. Sidevangene er fortrinnsvis forbundet innbyrdes med avstivningsstenger (15A-C), av rundttre, som strekker seg gjennom sidevangene.
Patent NO-930600-L (NO)
Inventor: SAUERBERG PER
IPC: C07D413/04
Filed: 1993-02-19
Abstract: The present invention relates to therapeutically active azacyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful as stimulants of the cognitive function of the forebrain and hippocampus of mammals and especially in the treatment of Alzheimer's disease, severe painful conditions and glaucoma.
Patent NO-933241-L (NO)
Inventor: ROSINI SERGIO
IPC: C07C235/70
Filed: 1993-09-10
Abstract: PCT No. PCT/EP92/00479 Sec. 371 Date Oct. 6, 1993 Sec. 102(e) Date Oct. 6, 1993 PCT Filed Mar. 4, 1992 PCT Pub. No. WO92/16496 PCT Pub. Date Oct. 1, 1992.The present invention concerns a compound of formula (I)    <IMAGE>   wherein: X is selected from H and OH; R is a residue which, linked to the   mers and racemic mixtures thereof; and the pharmaceutically acceptable salts thereof. The invention further concerns a pharmaceutical composition which comprises the above compound or salts thereof and the use of the compound for treating an articular pathology.
Patent NO-940594-L (NO)
Inventor: BECK JOSEF
IPC: F03C1/253
Filed: 1994-02-21
Abstract: PCT No. PCT/EP92/01611 Sec. 371 Date Jun. 20, 1994 Sec. 102(e) Date Jun. 20, 1994 PCT Filed Jul. 16, 1992 PCT Pub. No. WO93/04281 PCT Pub. Date Mar. 4, 1993.An axial piston motor of adjustable swept volume for installation in a wheel hub, having a motor housing which is open on one side and is closed by a connection block, an output shaft rotatably mounted in the housing and a connection block, an adjusting device for adjusting the swept volume, a step-down gear unit driven by the output shaft and having a driving toothed wheel for the drive of the wheel hub, and a brake associated with the output shaft on the connection block. For the purpose of reducing the outlay in terms of construction, with comparatively compact dimensions, and for greater ease of external access to the adjusting device, the step-down gear unit (13) is arranged inside the motor housing (1, 3) with two-sided mounting of the driving toothed wheel (47) and the connection block (5) is set back radially with respect to the motor housing (1) and the adjusting device (28, 29, 30) is arranged so as to be freely externally accessible in the region (23) of the motor housing (1, 2) that is free of covering.
Patent NO-941162-L (NO)
Inventor: BACON EDWARD R
IPC: C07C63/307
Filed: 1994-03-29
Abstract: Dicarboxylic acid derivs. of formula Z-COO-C(COOR1)(COOR2)R3 (I) are new. Z-COO = the residue of an iodinated aromatic acid (IAA); R1, R2 = alkyl, fluoroalkyl, cycloalkyl, aryl or aralkyl; R3 = H, alkyl, fluoroalkyl, cycloalkyl, aryl, aralkyl, alkoxy, aryloxy, CN, sulphonate, carboxamido, sulphonamido, alkoxycarbonyl, aryloxycarbonyl or aralkoxycarbonyl. 1AA = metrizoic, urokanic, iothalanic, trimesic, ioxagalic, ioxitalamic or tetraiodoterephthalic acid, iodipamide or esp. diatrizoic acid; R1, R2 = CF3; R3 = H, Me or CF3.
Patent NO-944076-L (NO)
Inventor: SAMPSON RICHARD L
IPC: C25B9/00
Filed: 1994-10-26
Abstract: The invention is directed to a method for on-site halogen treatment of dilute aqueous solutions comprising adding a halide salt to at least the portion of said aqueous solution, contacting at least the portion of said aqueous solution containing said halide salt with a modified cation exchange material interposed between an anode and a cathode of an electrolytic reactor, in which a direct current is applied across the anode and the cathode, for a time to cause free radical formation in said modified cation exchange material and oxidation of at least a portion of said halide salt to halous acid by said modified cation exchange material, which halous acid then oxidizes undesirable contaminants in said dilute aqueous solution. The invention further relates to a system for on-site halogen treatment of dilute aqueous solutions.
Patent NO-953642-L (NO)
Title: Blandinger som er nyttige ved alkenpolymerisasjon og fremgangsmåter for fremstilling av blandingen og alkenpolymerisasjon med blandingen
Inventor: PETTIJOHN TED M
IPC: C08F4/60
Filed: 1995-09-15
Abstract: En blanding som kan bli anvendt som katalysator for fremstilling av enalkenpolymer som har en multimodal molekylvektfordeling er tilveiebragt, som omfatter en overgangsmetallholdig katalysator, en metallocen og et borholdig organoaluminoksan, hvori hver komponent i blandingen er til stede i en effektiv mengde slik at et alkenpolymer som har en multimodal molekylvektfordeling kan fremstilles i ved å benytte blandingen som katalysator, ! fortrinnsvis i nærvær av en kokatalysator. Det er ; også tilveiebragt en fremgangsmåte til å fremstille ; blandingen som omfatter: (1) å bringe i kontakt en overgansmetallholdig katalysator med et organo- , aluminoksan disbergert i et oppløsningsmiddel til å | danne en slurry; (2) å kombinere slurrien med et boroksin for å fremstille en kombinasjon av en overgangsmetallholdig katalysator og borholdig organoaluminoksan; og (3) å bringe kombinasjon i kontakt med et metallocen. Videre er det tilveie- ; bragt en prosess for å polymerisere et alken for å fremstille et alkenpolymer ved å anvende blandingen.
Patent NO-954457-L (NO)
Inventor: OSTERBERG THOMAS
IPC: A61K38/37
Filed: 1995-11-07
Abstract: PCT No. PCT/SE94/00265 Sec. 371 Date Oct. 30, 1995 Sec. 102(e) Date Oct. 30, 1995 PCT Filed Mar. 24, 1994 PCT Pub. No. WO94/26286 PCT Pub. Date Nov. 24, 1994The present invention relates to a final drug product comprising coagulation factor VIII in an aqueous solution with a reduced concentration of oxygen. In this way, the factor VIII activity can be retained during storage to a surprisingly high degree. The factor VIII activity can be retained for a prolonged period of time, if the final drug product further comprises an inert gas and/or an antioxidant. The present invention also relates to processes for reducing the oxygen concentration of the aqueous solution, and a method for improving the stability of factor VIII in an aqueous solution by storing the solution under an inert gas atmosphere. By the present invention it is possible to retain at least 50% of the initial activity of factor VIII after storage for at least 6 months at a temperature of 2 to 10 DEG  C. and a pH of the solution of 6.5 to 8.5.
Patent NO-961736-L (NO)
Title: Væskeseparator og poleringsfilter
Inventor: ROSE WILLIAM C
IPC: C02F9/00
Filed: 1996-04-29
Abstract: Vannbehandlingsinnretning, især et transportabelt rensesystem for vann som 1 pumpes fra mannhull og utstyrshvelv. Separasjon av vann og forurens- ningsstoffer blir gjennom med et femmodulsystem. De første moduler fjerner 98 % av faste stoffer fra avfallsvanns- j trømmen ved bruk av en rekke vaffelpla- ter. Modul 2 fjerner fri olje som er tilstede i væskestrømmen med en koal- iserende vann/oljeseparator. Den tredje modulen fjerner faste stoffer som frem- deles finnes i strømmen, som er større enn 20 mikron, ved bruk av et størrel- sesdiskriminerende filter. Den fjerde og ; den femte modul er bindingstanker som brukes til å innkapse hhv hydrokarboner ¿ og tungmetaller. Den sekvens i hvilken den forurensede strøm entrer hver av modulene er essensiell for effektivitet- en av filtreringsprosessen. Rensefilte- ret for vannbehandlingssystemet som har evnen til å fjerne små faste partikler og hydrokarboner som er tilstede i en væskestrøm er en filtreringsanordning som kan brukes enten i forbindelse med l allerede eksisterende prosesser eller som en frittstående enhet. Rensefilteret kan brukes for marine, kommersielle i eller industrielle aktiviteter. Små faststoffer vil bli diskriminert etter størrelse ved et fjernbart og utskift- bart posefilter. Inne i posefilteret er det et rensefilter-bindingsmedium, hydrokarbon-innkapslingsagens som brukes til å separere og binde emulgerte og oppløste oljer. Dette bindingsmedium er oppbevart inne i en porøs membranpose som er også fjernbar og utskiftbar. Bruk !av denne innretningen i tillegg til allerede eksisterende utstyr som benyt- tes av sjøgående fartøyer og kommer- sielle og industrielle aktiviteter vil forbedre rengjøringsprosessen og hjelpe med å tilfredsstille lokale, nasjonale og internasjonale lover om rent vann for utslipp fra skip og vannbaserte akti- viteter.
Patent NO-962984-L (NO)
Inventor: WEISS STEFAN
IPC: C07C277/02
Filed: 1996-07-17
Abstract: Prepn. of creatine or creatine monohydrate comprises reaction of the sodium or potassium salt of sarcosine with cyanamide in water or a mixture of water and organic solvent at 20-150 degrees C and at pH 7.0-14.0. Reaction temp. is 50-100 degrees C, pH = 9.0-10.0 and acid regulated, molar ratio cyanamide:sarcosinate salt is 1:4-4:1 (pref. 0.9:1-1.25:1), sarcosine salt being present as a 35-45 wt.% aq. soln. and the cyanamide as pref. 50 wt.% aq. soln. Pref. organic solvent is a 1-5C aliphatic alcohol. Reaction product is purified by and recrystallised from water. Dry creatine product is less than 1 wt.% and the monohydrate has approx. 12.1 wt.% water content.
Patent NO-964313-L (NO)
Inventor: DEKKERS HENK
IPC: B65D1/24
Filed: 1996-10-10
Abstract: Crate with a bottom (1) and vertical sidewalls (3-6), and a partitioning grid (9) dividing the interior of the crate into compartments (10), in which containers such as bottles is to be accommodated. The sidewall parts (12, 13, 14, 15) of at least one compartment (10) are designed for laterally supporting a container placed in the compartment and defines an imaginary cylinder whose axis slants at a certain angle ( alpha ) relative to the bottom (1) of the crate. Said angles lie, for example, between 85 DEG  and 89 DEG , preferably between 86 DEG  and 87 DEG . Such a crate is suitable for the accommodation of containers of different diameters, the containers assuming a firm position in the compartment in question.
Patent NO-964451-L (NO)
Title: Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer
Inventor: RUDDY STEPHEN B
IPC: A61K49/04
Filed: 1996-10-18
Abstract: Det er beskrevet røntgenkontrastmidler for oral eller retrograd undersøkelse av tarmkanalen, og hvor nevnte middel inneholder et røntgenkontrastmiddel i kombinasjon med en farmasøytisk akseptabel leire i et farmasøytisk akseptabelt bærestoff, foruten fremgangsmåter for deres anvendelse i diagnostisk radiologi av tarmkanalen.
Patent NO-970215-L (NO)
Inventor: HANSSON HANS-ARNE
IPC: A61P19/00
Filed: 1997-01-17
Abstract: PCT No. PCT/SE95/00857 Sec. 371 Date Aug. 30, 1995 Sec. 102(e) Date Aug. 30, 1995 PCT Filed Jul. 13, 1995 PCT Pub. No. WO96/02259 PCT Pub. Date Feb. 1, 1996The use of chitosan and a polysaccharide immobilized thereto selected from heparin, heparan sulphate, chondroitinsulphates and dextran sulphate for the manufacture of an agent capable of providing stimulated regeneration of hard tissue; a process for stimulating regeneration of hard tissue in connection with so called osseointegration; and implant intended for integration into hard tissue, particularly bone tissue.
Patent NO-971250-L (NO)
Inventor: ALLAGNAT BERNARD
IPC: B07B13/00
Filed: 1997-03-18
Abstract: PCT No. PCT/FR95/01193 Sec. 371 Date Mar. 17, 1997 Sec. 102(e) Date Mar. 17, 1997 PCT Filed Sep. 18, 1995 PCT Pub. No. WO96/09127 PCT Pub. Date Mar. 28, 1996A device including an annular rotary tray (1) surrounding a central space (4) housing a waste infeed and discharge assembly (14). An adjustable flap (10) selectively urges the waste on the rotary tray (1) towards the edge or the center thereof. A loading belt (6) delivers the waste onto the rotary tray (1). As the rotary tray (1) rotates in one direction, the adjustable flap (10) gradually urges the waste towards personnel located at the periphery of the tray or towards a discharge chute. When the rotary tray (1) is rotated in the opposite direction, said adjustable flap (10) returns uncollected waste to the central space (4) for discharge.